Norovirus is increasingly recognized as a frequent cause of non-bacterial gastroenteritis. Despite a 10-fold increase in the number of cases reported following the availability of enzyme immunoassays, there are no reports yet from preterm neonates. We report on a sudden clustering of antigen-positive enzyme immuno assays results in a level III neonatal intensive care unit, involving 22 of 43 infants screened. Although antigen-positive samples were significantly associated with bloody stools (P<0.001) and gastric residues (P<0.02), norovirus infection could not be confirmed by reversetranscriptase polymerase chain reaction or electron microscopy. We question the validity of the so called norovirus-specific antigen assays and warn against overreacting to positive enzyme immunoassays results without reverse-transcriptase polymerase chain reaction confirmation especially in the neonatal setting.
Introduction
Norwalk virus, the prototype strain of noroviruses, was first characterized in 1972 and norovirus were soon identified as a frequent cause of endemic non-bacterial gastroenteritis. Currently, norovirus (NoV) is thought to be responsible for 13-30% of episodes of viral gastroenteritis, particularly in hospitals or nursing homes. [1] [2] [3] As attempts to produce viral cultures have been unsuccessful, 4 development and assessment of diagnostic methods aimed at detecting norovirus have proven difficult and require electron microscopy or reverse-transcriptase polymerase chain reaction (RT-PCR), 5, 6, 8 for which specificity and sensitivity have been reported to be at 98.0% and 58.3% and 92.4% and 94.1%, respectively. 5 In 2001, an enzyme immunoassay (EIA) has become commercially available and is intended to facilitate diagnosis of this viral infection. 5, 7 According to the manufacturer this test is licensed for humans, neonates are not excluded.
During a 3-day period in early November 2003, three infants admitted to the neonatal intensive care unit at Tuebingen Children's Hospital developed bloody stools; one of them subsequently developed necrotizing enterocolitis requiring surgery. The latter infant had positive stool cultures for Clostridium clostridiforme and positive EIA results for rota-and adenovirus, while the other two had no pathogens identified. The three infants were then screened for norovirus-antigens using the IDEIA NLV kit (DakoCytomation Ltd., Ely, UK), with positive EIA results in all cases. Triggered by this unexpected finding, stool samples from all neonates being treated in the department at that time was screened for NoV and clinical data were collected. A total of 163 stool samples were obtained over a 3-week period. Stool samples were tested either directly or stored at À20 1C until testing. The norovirus antigen EIA (DAKO) was performed according to the manufacturer's instructions using the same lot number on all specimens. Any specimen with an absorbance value (OD S ) greater than the cutoff value (OD CO ) recommended by the manufacturer was considered positive for the respective genogroup I or II (OD S/CO -ratio >1).
Using this test kit, 46 of 163 samples tested positive for norovirus antigen, involving 22 of 43 infants tested. Of these 46 samples, 18 showed OD S/CO -ratios >2 and 28 OD S/CO -ratios <2. Thirty-seven samples were reactive for genogroup I, of which nine (25%) showed OD S/CO -ratios >2, 1 sample was reactive for genogroup II with OD S/CO -ratio 5.6, and eight samples were reactive for both, genogroup I and II, all (100%) with OD S/CO -ratios >2 (data shown in part in Table 1 ).
To confirm this unexpected finding, RT-PCR was performed at the reference laboratory for Norovirus (Robert Koch Institute, Berlin) as described by Schreier et al. 8 and Oh et al. 3 Viral nucleic acids were extracted from 140 ml of a 10% fecal suspension by the use of a spin-column technique according to the manufacturer's instructions (QIAGEN, Hilden, Germany) and nucleic acids was eluted in 60 ml 10 mM Tris-HCl, pH 7.0. Five microliters of the extracted RNA was reverse transcribed using M-MLV-RT (Life Technologies, Gaithersburg, MD, USA) and primer NV36. 8 Part of the cDNAs were amplified by nested PCR using primers NV32/NV32a/NV36 for the first round, and primers NV35/NV35a/NV33/NV33a for the second round PCR. A complete overview of the primer sequences used is given in Oh et al. Specificity of the method is reported to be 92.4%, with sensitivity at 94.1%. 5 Of all stool samples only 11 could be tested by RT-PCR due to small specimen volume in preterm infants. All 11 samples were RT-PCR negative for NoV (Table 1) , and additionally 8 of these 11 samples were tested for sapovirus infection with negative results. Given these discrepancies, these stool specimens were also investigated via electron microscopy 9 without detection of virus like particles.
The first three infants who had developed bloody stools were isolated and cared for using gowns and gloves. With the detection of additional apparently norovirus-positive EIA results, such infants were cohorted on one ward that was closed for any other admission. Clinical symptoms were evaluated on the same day the stool samples were collected, using structured forms. Symptoms were compared between EIA-positve and EIA-negative infants using the w 2 test, with a P-value <0.05 being considered statistically significant. These comparisons showed a higher proportion of bloody stools among EIA-positive samples (11/46 vs 1/117, P<0.001, w 2 test) as well as gastric residues (6/46 vs 4/117, P<0.02). Infants with norovirus antigen-positive stool samples also had a lower post-conceptional age at the time their stool samples were obtained (median 34.9 week (range, 28.6-40.9) vs 36.6 week (range, 29.4-66.9), P<0.001). All other parameters evaluated (volume and frequency of stools per day, weight gain, vomiting, episodes of apnea, bradycardia and/or desaturation, greyish skin color, number of infants receiving breast milk) were not significantly different between groups.
Discussion
These data raise several important points. Norovirus antigenpositive stool samples from preterm neonates have not yet been reported; thus, there is no information as to whether these stools may contain any substance that makes false positive EIA results more likely. In our case series, confirmation by RT-PCR was attempted in less than one quarter of EIA-positive samples; yet the fact that norovirus could not be detected in any suggests poor agreement between the two diagnostic methods. The same is true for our data on transmission electron microscopy.
Given that the sensitivity of RT-PCR was found to be high (94%), 5 we must question the specificity of the EIA test used in this setting. Recent findings by the Centre for Disease Control (Atlanta, USA) showed a specificity of 100% and a sensitivity of only 39% for the norovirus antigen EIA (DAKO) using highly RT-PCR-positive reference samples of genogroup I and II NoV. Interestingly, four subgroups of NoV genogroup II were not detectable by the DAKO kit. 7 In addition another study in hospitalized children evaluating two commercial EIAs found sensitivity and specificity to be 76.9% and 85.9% when compared with RT-PCR. 10 Other reports showed a high molecular diversity and multiple mutations during outbreaks in the United Kingdom or Japan. 11, 12 Obviously, as all test results were obtained with the same lot, we cannot exclude kit-specific false positive results.
What remains unexplained are the symptoms found in several infants that triggered this investigation. For example, the influence 13 In addition the gut flora in neonates and especially premature neonates could differ from infants and adults, thus explaining discrepancies between the DAKO kit's evaluation trials and our results, 14 but this explanation is unlikely given that this test is licensed for use in humans, including neonates. Based on the data described above, we question the high specificity of certain norovirus antigen EIA suggested in published investigations, 7, 15 particularly considering the consequences, that is, the cost and logistic problems caused by the hygienic measures such as ward closures resulting from positive NoV results. We call for studies into the specificity of these tests for norovirus detection in stool samples from neonates.
